Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Shionogi discloses ACC2 inhibitors

Oct. 20, 2016

Merck & Co. patents TrK-A inhibitors

Oct. 20, 2016

Arisan Therapeutics presents RNA polymerase inhibitors

Oct. 19, 2016

Celon Pharma develops PI3Kdelta inhibitors

Oct. 19, 2016

Enanta Pharmaceuticals describes FXR agonists

Oct. 19, 2016

Shenyang Sunshine Pharmaceutical discloses EGLN1 inhibitors

Oct. 19, 2016

Takeda Pharmaceutical patents enteropeptidase inhibitors

Oct. 19, 2016

Toray Industries presents kappa-opioid agonists

Oct. 18, 2016

Jubilant Biosys develops HUNK1 inhibitors

Oct. 18, 2016

Takeda Pharmaceutical describes MGL inhibitors

Oct. 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...